← Browse by Condition
Medical Condition

durvalumab

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06999694 Phase 2
Recruiting

Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC

Enrollment
45 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
View Trial →